CLOs on the Move

Endologix

www.endologix.com

 
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Elisa Hebb
 Vice President, Clinical and Regulatory Affairs Profile
Christopher LaQuay
 Associate General Counsel Profile

Similar Companies

RFTechnologies

RFTechnologies is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

schwartz john c dds a professional corp

schwartz john c dds a professional corp is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroAire

MicroAire is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Contego Medical

Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.

Gri Medical Products Inc

Gri Medical Products Inc is a Cave Creek, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.